The debate over the benefits of detecting and
treating subclinical hypothyroidism is still raging in the health world.
Treating subclinical hypothyroidism with levothyroxine has no effect on overall mortality rates, according to research presented today at the European Congress of Endocrinology in Wrocław, Poland.
«There is consensus to
treat subclinical hypothyroidism because it is generally believed that the potential benefits of treatment outweigh the potential risks of overtreatment,» said Tim Korevaar, MD, the study's lead investigator and a PhD student at Erasmus University in Rotterdam, the Netherlands.
Not exact matches
Using readily - available registry data, we were able to examine a large population and compare
treated versus untreated
subclinical hypothyroidism patients with respect to all - cause mortality.»
Guidelines clearly state that in order to avoid pregnancy complications and impaired development of offspring, women with
subclinical hypothyroidism need to be
treated with thyroid hormones.
Korzeniowska and Colleagues at the Medical University of Gdansk found that
treating children with
subclinical hypothyroidism with thyroid hormones resulted in a decrease of inflammation.
RESULTS: Seven patients in the iodine -
treated group developed
subclinical hypothyroidism and one patient became hypothyroid.
Seven patients in the iodine -
treated group developed
subclinical hypothyroidism and one patient became hypothyroid.
As patients, it is essential to understand the reality of
subclinical hypothyroidism and recognize the importance of having it properly
treated.
It is clear that recognition of
subclinical hypothyroidism is an issue, but is there a need to
treat it?